ruthenium has been researched along with Adenocarcinoma Of Kidney in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Contel, M; Elie, BT; Hubbard, K; Layek, B; Pechenyy, Y; Prabha, S | 1 |
1 other study(ies) available for ruthenium and Adenocarcinoma Of Kidney
| Article | Year |
|---|---|
Preclinical evaluation of an unconventional ruthenium-gold-based chemotherapeutic: RANCE-1, in clear cell renal cell carcinoma.
Topics: Angiogenic Proteins; Animals; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Proliferation; Cell Survival; Female; Gene Expression Regulation, Neoplastic; Gold; Humans; Kidney Neoplasms; Male; Mice; Organometallic Compounds; Ruthenium; Treatment Outcome; Xenograft Model Antitumor Assays | 2019 |